Endovia Health Sciences, Inc.
No SEC Form 4 filings for $EDVA in the last 30 days.
See all $EDVA insider activity →Worthington Enterprises (NYSE:WOR) shares rose 15.9% in pre-market trading after reporting Q1 earnings of $0.82 per share, beating estimates of $0.75, and sales of $343.89M, exceeding expectations of $331.27M.
Endovia Health Sciences (AMEX:EDVA) stock rose 47.83% in after-hours trading to $0.34 after securing initial funding from C/M Capital Master Fund. The funds support CannEpil's development, including FDA-regulated veterinary programs. The company has a market cap of $1.61M and a 52-week range of $0.23-$0.46.
Endovia Health Sciences, Inc. (EDVA) filed an SEC Form 8-K — Regulation FD Disclosure. EXHIBIT 99.1 Endovia Health Sciences Closes Initial $500,000 Financing to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways Initial funding represents first tranche of previously announced $1 million C/M Capital commitment supporting CannEp
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning EDVA (Endovia Health Sciences, Inc.). Coverage has skewed bullish: 2 bullish, 1 neutral, and 0 bearish.
Recent EDVA coverage spans corporate actions, earnings and technology.
Funding news supports share price.
The capital infusion supports CannEpil development and may lift the stock further.
The financing provides immediate capital for regulatory and clinical progress, likely supporting short‑term share price stability or modest upside.
Minor dilution and cash inflow; limited price impact expected.
Endovia Health Sciences, Inc. (SBEV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement On August 20, 2026, Endovia Health Sciences, Inc. (the “Company”) entered into an Employment Agreement (each, an “Agreement”) with each of Brady Cobb for his employment as Interim Chief Executive Officer of the Company and Mich
AlphAI scores every news story that mentions EDVA with an AI model for sentiment and relevance, and aggregates insider trades from Endovia Health Sciences, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Worthington Enterprises (NYSE:WOR) shares rose 15.9% in pre-market trading after reporting Q1 earnings of $0.82 per share, beating estimates of $0.75, and sales of $343.89M, exceeding expectations of $331.27M.
2 min readEndovia Health Sciences (AMEX:EDVA) stock rose 47.83% in after-hours trading to $0.34 after securing initial funding from C/M Capital Master Fund. The funds support CannEpil's development, including FDA-regulated veterinary programs. The company has a market cap of $1.61M and a 52-week range of $0.23-$0.46.
1 min readEndovia Health Sciences, Inc. (EDVA) filed an SEC Form 8-K — Regulation FD Disclosure. EXHIBIT 99.1 Endovia Health Sciences Closes Initial $500,000 Financing to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways Initial funding represents first tranche of previously announced $1 million C/M Capital commitment supporting CannEp
2 min readEndovia Health Sciences, Inc. (EDVA) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. Item 3.02 Unregistered Sales of Equity Securities. On August 25, 2026, Endovia Health Sciences, Inc. (the “Company”) sold and issued a total of 510,951 shares of common stock pursuant to that certain Securities Purchase Agreement dated September 19, 2025 with C/M Capital Master F
1 min readEndovia Health Sciences, Inc. (SBEV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement On August 20, 2026, Endovia Health Sciences, Inc. (the “Company”) entered into an Employment Agreement (each, an “Agreement”) with each of Brady Cobb for his employment as Interim Chief Executive Officer of the Company and Mich
1 min readSPLASH BEVERAGE GROUP, INC. (SBEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Splash Beverage Reports Second Quarter 2026 Results and Highlights Strategic Transformation Toward Endovia Health Sciences The Company’s loss from continuing operations declined by approximately 64% for the first six months of 2026 as cost reductions take hold FORT L
1 min readSPLASH BEVERAGE GROUP, INC. (SBEV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement On July 31, 2026, Splash Beverage Group, Inc. (the “Company”) entered into a Development and Collaboration Agreement (the “Collaboration Agreement”) with Lupvindol Biosciences Ltd. (“Lupvindol”), pursuant to which Lupvindol has
6 min readSplash Beverage Group Inc. (NYSE:SBEV) shares are trending on Friday. Shares of the Florida-based company climbed 64.10% to $0.57 after the bell on Thursday. The surge in the late trading session follows an intraday gain of 7.07% which closed the SBEV at $0.35, according to Benzinga Pro data. Splash Beverage Group, which engages in the manufacturing, distribution, marketing, and sale of various beverages, experienced an exceptionally elevated trading session on Thursday.
5 min readSPLASH BEVERAGE GROUP, INC. (SBEV) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EXHIBIT 99.1 Splash Beverage Group Expands CannEpil® Platform into Veterinary Therapeutics, Establishing Second FDA-Regulated Pharmaceutical Development Program Expansion broadens CannEpil into veterinary therapeutics as Splash advances its cannabinoid pharmaceutical development
4 min readSplash Beverage Group (NYSE American: SBEV) said it expanded its exclusive global CannEpil license to cover veterinary therapeutics. The company plans initial evaluation for companion-animal oncology and chronic pain, pursuing FDA Center for Veterinary Medicine INAD and Conditional Approval pathways. Splash will pay Argent BioPharma a 10% royalty on veterinary net revenues.
4 min read
